Trademark: 79347617
Word
INVOX
Status Date
Tuesday, March 26, 2024
Registration Number
7333791
Registration Date
Tuesday, March 26, 2024
Filing Date
Thursday, May 26, 2022
Published for Opposition
Tuesday, January 9, 2024
5 Pharmaceuticals for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine; Pharmaceutical preparations and substances for oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the prevention and treatment of inflammation and infectious diseases; chemical preparations for pharmaceutical purposes, namely, for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the treatment of inflammation and infectious diseases; chemical reagents for medical use; biotechnological preparations for medical use for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the treatment of inflammation and infectious diseases; biological adjuvants for medical purposes; biochemical preparations for medical use for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the treatment of inflammation and infectious diseases; preparations for deodorizing air; medicated deodorants for health and medical purposes; oils for medical purposes; air purifying preparations, pharmaceutical preparations for inhalers; none of the aforesaid goods being disinfectants or sanitary preparations, and not being adapted for use as disinfectant or sanitisers; none of the aforesaid being goods for use in diagnostics or for use in the examination, processing, transportation or testing of veterinary or medical samples
36 Financing and equity investment services in the fields of pharmaceuticals, biotechnology life sciences; capital financing services in the fields of pharmaceuticals, biotechnology, life sciences; making direct and indirect investments, namely providing venture capital, private equity and investment funding for the development and commercialization of products and management of product portfolios in the fields of pharmaceuticals, biotechnology, life sciences; investment services, namely, asset and investment acquisition, and development services; none of the aforesaid services being in relation to the examination, processing, transportation or testing services relating to veterinary or medical samples; none of the aforesaid services being in relation to diagnostic applications by means of medical samples or in the field of laboratory automation for diagnostic purposes by means of medical samples, specimen handling or sample preparation or being in the field of software and IT services for enabling and/or supporting medical, patient and veterinary sample data testing, processing and/or analysis
45 Licensing of intellectual property rights; licensing of intellectual property in the field of pharmaceutical, biotechnology, life sciences; none of the aforesaid being in relation to the examination, processing, transportation or testing services relating to veterinary or medical samples; none of the aforesaid services being in relation to diagnostic applications by means of medical samples or in the field of laboratory automation for diagnostic purposes by means of medical samples, specimen handling or sample preparation or being in the field of software and IT services for enabling and/or supporting medical, patient and veterinary sample data testing, processing and/or analysis
10 Surgical instruments and apparatus, and medical devices, namely, inhalation devices in the field of drug delivery systems, excluding medical and veterinary sample containers, processing and analysis machines and test kits and personal protective equipment (PPE); inhalers for medical and pharmaceutical purposes; none of the aforesaid being goods for use in the examination, processing, transportation or testing of veterinary or medical samples or for use in diagnostics or in laboratory automation for diagnostic purposes, sample handling or sample preparation enabling and/or supporting medical, patient and veterinary data testing, processing and/or analysis
42 Pharmaceutical research and development in the field of biotechnology, medical devices in the field of drug delivery systems; scientific research for clinical, medical and pharmaceutical purposes in the field of biotechnology, medical devices for drug delivery systems and life sciences; scientific research and development in the field of biotechnology medical devices, life sciences and healthcare technology; pharmaceutical products development and medical device product development in the field of biotechnology, medical devices for drug delivery systems and life sciences; none of the aforesaid being in relation to the examination, processing, transportation or testing services relating to veterinary; none of the aforesaid services being in relation to diagnostic applications by means of medical samples or in the field of laboratory automation for diagnostic purposes by means of medical samples, specimen handling or sample preparation or being in the field of software and IT services for enabling and/or supporting medical, patient and veterinary sample data testing, processing and/or analysis
May 4, 2023
Refusal Processed By Mpu
Aug 18, 2022
Sn Assigned For Sect 66a Appl From Ib
Aug 19, 2022
New Application Office Supplied Data Entered
Aug 23, 2022
Application Filing Receipt Mailed
Mar 14, 2023
Assigned To Examiner
Mar 15, 2023
Non-Final Action Written
Mar 16, 2023
Non-Final Action (Ib Refusal) Prepared For Review
May 4, 2023
Non-Final Action Mailed - Refusal Sent To Ib
May 24, 2023
Refusal Processed By Ib
Jul 30, 2023
Limitation Of Goods Received From Ib
Oct 24, 2023
Limitation From The Ib - Request Exam Review
Nov 6, 2023
Teas Response To Office Action Received
Nov 6, 2023
Correspondence Received In Law Office
Nov 7, 2023
Teas/Email Correspondence Entered
Dec 20, 2023
Notification Of Possible Opposition Sent To Ib
Dec 20, 2023
Notification Of Notice Of Publication E-Mailed
Dec 20, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 9, 2024
Published For Opposition
Jan 9, 2024
Official Gazette Publication Confirmation E-Mailed
Dec 5, 2023
Approved For Pub - Principal Register
Jan 8, 2024
Notification Processed By Ib
Jan 24, 2024
Notification Of Possible Opposition Sent To Ib
Jan 24, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Feb 13, 2024
Notification Of Possible Opposition - Processed By Ib
Mar 26, 2024
Registered-Principal Register
Mar 26, 2024
Notice Of Registration Confirmation Emailed
Jun 27, 2024
Final Disposition Notice Created, To Be Sent To Ib
Trademark Alertz updated from USPTO on 2030-01-24
